Table of Contents Author Guidelines Submit a Manuscript
Autoimmune Diseases
Volume 2012, Article ID 969657, 12 pages
http://dx.doi.org/10.1155/2012/969657
Review Article

Is Multiple Sclerosis an Autoimmune Disease?

1Departments of Neurology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
2Division of Neurology, Saga University Faculty of Medicine, Saga 849-8501, Japan
3Department of Internal Medicine and Advanced Comprehensive Functional Recovery Center, Saga University Faculty of Medicine, Saga 849-8501, Japan
4Departments of Immunology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA

Received 30 January 2012; Revised 5 March 2012; Accepted 15 March 2012

Academic Editor: Hiroshi Ikegami

Copyright © 2012 Bharath Wootla et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [22 citations]

The following is the list of published articles that have cited the current article.

  • Ava Sheikhi Shoshtari, Sue-Jin Lin, Martin J. McKeown, and Z. Jane Wang, “A Multimodal data fusion approach efficiently predicts disease duration in multiple sclerosis,” 2016 International Joint Conference on Neural Networks (IJCNN), pp. 4518–4524, . View at Publisher · View at Google Scholar
  • Matthew F. Cusick, and Jane E. Libbey, “Multiple sclerosis: autoimmunity and viruses,” Current Opinion in Rheumatology, vol. 25, no. 4, pp. 496–501, 2013. View at Publisher · View at Google Scholar
  • Peter K. Stys, “Pathoetiology of multiple sclerosis: Are we barking up the wrong tree?,” F1000 Prime Reports, vol. 5, 2013. View at Publisher · View at Google Scholar
  • R. Alroughani, S. Lamdhade, and A. Thussu, “Endovascular treatment of chronic cerebrospinal venous insufficiency in multiple sclerosis: a retrospective study,” International Journal Of Neuroscience, vol. 123, no. 5, pp. 324–328, 2013. View at Publisher · View at Google Scholar
  • J.O. Fleming, “Helminth therapy and multiple sclerosis,” International Journal for Parasitology, vol. 43, no. 3-4, pp. 259–274, 2013. View at Publisher · View at Google Scholar
  • Raphael Schneider, “Autoantibodies to potassium channel KIR4.1 in multiple sclerosis,” Frontiers in Neurology, vol. 4, 2013. View at Publisher · View at Google Scholar
  • Ronald Ross Watson, and Gurman Dhaliwalpp. 293–302, 2014. View at Publisher · View at Google Scholar
  • Pamela K. Newland, Louise H. Flick, Florian P. Thomas, and William D. Shannon, “Identifying Symptom Co-Occurrence in Persons With Multiple Sclerosis,” Clinical Nursing Research, vol. 23, no. 5, pp. 529–543, 2014. View at Publisher · View at Google Scholar
  • Peter O. Behan, and Abhijit Chaudhuri, “EAE is not a useful model for demyelinating disease,” Multiple Sclerosis and Related Disorders, vol. 3, no. 5, pp. 565–574, 2014. View at Publisher · View at Google Scholar
  • Bharath Wootla, Aleksandar Denic, and Moses Rodriguez, “Polyclonal and monoclonal antibodies in clinic,” Methods in Molecular Biology, vol. 1060, pp. 79–110, 2014. View at Publisher · View at Google Scholar
  • Bharath Wootla, Aleksandar Denic, and Moses Rodriguez, “Polyclonal and monoclonal antibodies in clinic,” Methods in Molecular Biology, vol. 1060, pp. 79–110, 2014. View at Publisher · View at Google Scholar
  • Lidia De Riccardis, Antonia Rizzello, Alessandra Ferramosca, Emanuela Urso, Francesca De Robertis, Antonio Danieli, Anna Maria Giudetti, Giorgio Trianni, Vincenzo Zara, and Michele Maffia, “Bioenergetics profile of CD4(+) T cells in relapsing remitting multiple sclerosis subjects,” Journal Of Biotechnology, vol. 202, pp. 31–39, 2015. View at Publisher · View at Google Scholar
  • Melissa A. Partridge, Simon J. Myers, Sumana Gopinath, and Jens R. Coorssen, “Proteomics of a conundrum: Thoughts on addressing the aetiology versus progression of multiple sclerosis,” PROTEOMICS - Clinical Applications, 2015. View at Publisher · View at Google Scholar
  • George Anderson, and Moses Rodriguez, “Multiple sclerosis: The role of melatonin and N-acetylserotonin,” Multiple Sclerosis And Related Disorders, vol. 4, no. 2, pp. 112–123, 2015. View at Publisher · View at Google Scholar
  • Lidia De Riccardis, Antonia Rizzello, Alessandra Ferramosca, Emanuela Urso, Francesca De Robertis, Antonio Danieli, Anna Maria Giudetti, Giorgio Trianni, Vincenzo Zara, and Michele Maffia, “Bioenergetics profile of CD4+ T cells in relapsing remitting Multiple Sclerosis subjects,” Journal of Biotechnology, 2015. View at Publisher · View at Google Scholar
  • Francesca Gilli, Libin Li, Sandra J. Campbell, Daniel C. Anthony, and Andrew R. Pachner, “The effect of B-cell depletion in the Theiler's model of multiple sclerosis,” Journal of the Neurological Sciences, vol. 359, no. 1-2, pp. 40–47, 2015. View at Publisher · View at Google Scholar
  • Izaskun Buendia, Patrycja Michalska, Elisa Navarro, Isabel Gameiro, Javier Egea, and Rafael León, “Nrf2-ARE Pathway: An emerging target against oxidative stress and neuroinflammation in neurodegenerative diseases,” Pharmacology & Therapeutics, 2015. View at Publisher · View at Google Scholar
  • Elena Michailidou, Carmen Simal, Theodore Tselios, Mary Patricia Yannakakis, Haralambos Tzoupis, and Efthimia Mantzourani, “Molecular dynamics at the receptor level of immunodominant myelin oligodendrocyte glycoprotein 35–55 epitope implicated in multiple sclerosis,” Journal of Molecular Graphics and Modelling, vol. 68, pp. 78–86, 2016. View at Publisher · View at Google Scholar
  • Yuan Zhang, Rongrong Huang, Yanhong Zhang, Hongwei Yi, Ying Bai, Jie Chao, and Honghong Yao, “IL-17 induces MIP-1α expression in primary mouse astrocytes via TRPC channel,” Inflammopharmacology, vol. 24, no. 1, pp. 33–42, 2016. View at Publisher · View at Google Scholar
  • Lidia De Riccardis, Alessandra Ferramosca, Antonio Danieli, Giorgio Trianni, Vincenzo Zara, Francesca De Robertis, and Michele Maffia, “Metabolic response to Glatiramer acetate therapy in Multiple Sclerosis patients,” BBA Clinical, 2016. View at Publisher · View at Google Scholar
  • Andreia Barateiro, Dora Brites, and Adelaide Fernandes, “Oligodendrocyte Development and Myelination in Neurodevelopment: Molecular Mechanisms in Health and Disease,” Current Pharmaceutical Design, vol. 22, no. 6, pp. 656–679, 2016. View at Publisher · View at Google Scholar
  • Tatyana M. Sivtseva, Vsevolod A. Vladimirtsev, Tatyana K. Davidova, Vladimir L. Osakovsky, Raisa S. Nikitina, and Dygyn A. Popov, “Intrathecal synthesis of oligoclonal IgG in patients with Viliuisk encephalomyelitis: The relationship between oligoclonal bands and clinical features,” Journal of the Neurological Sciences, vol. 384, pp. 84–88, 2018. View at Publisher · View at Google Scholar